ALBEMARLE CORP ALB

Healthcare SIC 2821 - Plastic Materials, Synth Resins & Nonvulcan Elastomers NYSE

Albemarle Corporation was incorporated in Virginia in 1993. Our principal executive offices are located at 4250 Congress Street, Suite 900, Charlotte, North Carolina 28209. Unless the context otherwise indicates, the terms "Albemarle," "we," "us," "our" or "the Company" mean Albemarle Corporation and its consolidated subsidiaries.

Albemarle is a world leader in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health. Our purpose is to enable a more resilient world. We partner to pioneer new ways to move, power, connect, and protect. The end markets we serve include grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals and medical devices. We believe that our world-class resources with reliable and consistent supply, our leading process chemistry, high-impact innovation, customer centricity and focus on people and planet will enable us to maintain a leading position in the industries in which we operate.

Last close 126.28 2026-09-04
Market cap $14.90B 2026-06-30 share count
52-week range 71.25 - 221.00

Valuation FY2025 figures against the last close

P/S2.9x
P/E
P/FCF21.5x
EV/EBITDA56.5x
Dividend yield1.3%
Diluted EPS-5.76

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $5.14B$5.38B$9.62B$7.32B$3.33B$3.13B$3.59B$3.37B$3.07B$2.68B
Cost of revenue $4.47B$5.31B$8.43B$4.25B$2.33B$2.13B$2.33B$2.16B$1.97B$1.71B
Gross profit $668.7M$62.5M$1.19B$3.07B$998.0M$994.9M$1.26B$1.22B$1.11B$970.3M
R&D $51.4M$86.7M$85.7M$72.0M$54.0M$59.2M$58.3M$70.1M$84.3M$80.5M
SG&A $550.0M$618.0M$910.0M$524.1M$441.5M$429.8M$533.4M$446.1M$450.3M$353.8M
Operating income -$367.1M-$1.78B$251.9M$2.47B$798.4M$505.8M$666.1M$911.5M$571.7M$601.0M
Pre-tax income -$552.1M-$1.76B$246.7M$2.43B$133.6M$373.5M$563.0M$794.7M$446.8M$515.3M
Income tax $156.9M$87.1M$430.3M$390.6M$29.4M$54.4M$88.2M$144.8M$431.8M$96.3M
Net income -$510.6M-$1.18B$1.57B$2.69B$123.7M$375.8M$533.2M$693.6M$54.9M$643.7M
EPS, basic -5.76-11.2013.4122.971.073.535.036.400.495.73
EPS, diluted -5.76-11.2013.3622.841.063.525.026.340.495.68
Shares, diluted (wtd. avg.) $117.7M$117.5M$117.8M$117.8M$116.5M$106.8M$106.3M$109.5M$112.4M$113.2M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $1.62B$1.19B$889.9M$1.50B$439.3M$746.7M$613.1M$555.3M$1.14B$2.27B
Receivables $593.5M$742.2M$1.21B$1.19B$556.9M$530.8M$612.7M$605.7M$534.3M$486.0M
Inventory $1.18B$1.50B$2.16B$2.08B$798.6M$750.2M$769.0M$700.5M$592.8M$450.3M
Total current assets $4.01B$3.84B$5.22B$5.19B$1.99B$2.21B$2.23B$2.00B$2.48B$3.31B
Property, plant and equipment $5.91B$5.35B$4.91B$3.02B$2.49B$2.36B
Goodwill $1.50B$1.58B$1.63B$1.62B$1.60B$1.67B$1.58B$1.57B$1.61B$1.54B
Other intangibles $214.2M$230.8M$261.9M$287.9M$308.9M$349.1M$354.6M$386.1M$421.5M$354.6M
Total assets $16.37B$16.61B$18.27B$15.46B$10.97B$10.45B$9.86B$7.58B$7.75B$8.16B
Accounts payable $1.53B$600.5M$483.2M$574.1M$522.5M$418.5M$281.9M
Short-term debt $74.1M$398.0M$625.8M$2.1M$389.9M$804.7M$187.3M$307.3M$422.0M$247.5M
Total current liabilities $1.80B$1.97B$3.56B$2.74B$1.87B$1.80B$1.41B$1.18B$1.20B$1.14B
Long-term debt $3.12B$3.12B$3.54B$3.21B$2.00B$2.77B$2.86B$1.40B$1.42B$2.12B
Retained earnings $4.61B$5.48B$6.99B$5.60B$3.10B$3.16B$2.94B$2.57B$2.04B$2.12B
Total equity $9.53B$9.96B$9.67B$8.19B$5.81B$4.47B$4.09B$3.76B$3.82B$3.94B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $1.28B$687.9M$1.33B$1.91B$344.3M$798.9M$719.4M$546.2M$304.0M$735.5M
Depreciation and amortisation $658.7M$588.6M$429.9M$300.8M$254.0M$232.0M$213.5M$200.7M$196.9M$226.2M
Stock-based compensation $40.3M$32.1M$36.5M$30.5M$20.1M$22.8M$19.7M$15.2M$19.4M$17.0M
Capital expenditure $589.8M$1.68B$2.15B$1.26B$953.7M$850.5M$851.8M$700.0M$317.7M$196.7M
Investing cash flow -$146.0M-$1.58B-$2.56B-$1.42B-$666.6M-$863.6M-$1.66B-$303.7M-$357.8M$2.92B
Financing cash flow -$834.2M$1.24B$623.9M$611.9M$50.2M$177.3M$1.04B-$786.5M-$1.09B-$1.58B
Dividends paid $190.5M$188.5M$187.2M$184.4M$177.9M$161.8M$152.2M$144.6M$140.6M$135.4M
Buybacks $0$0$500.0M$250.0M$0

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000915913-26-000060.

Others in SIC 2821

TickerCompanyMarket capP/ERevenue growth
DOW DOW INC. $21.22B -7.0%
DD DuPont de Nemours, Inc. $17.77B 1.9%
EMN EASTMAN CHEMICAL CO $8.14B 17.4x -6.7%
HXL HEXCEL CORP /DE/ $6.96B -0.5%
AVNT AVIENT CORP $3.98B 48.8x 0.6%
ROG ROGERS CORP $2.28B -2.3%
PCT PureCycle Technologies, Inc. $1.28B
ASIX AdvanSix Inc. $471.2M 9.7x 0.3%